What Xbira is?
Abiraterone is a CYP17 inhibitor indicated for use:
- With the combination of corticosteroid for metastatic castration-resistant prostate cancer (mCRPC) as well as metastatic high-risk castration sensitive prostate cancer (mCSPC)
- May be effective in the prevention of testosterone flare at the initiation of Gonadotropin-Releasing Hormone Agonist (GnRH ) therapy in males with prostate cancer.
What Abiraterone Acetate is?
Abiraterone acetate, sold under the brand name Zytiga among others, is a medication used to treat prostate cancer. Specifically it is used together with a corticosteroid for metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC). It should either be used following removal of the testicles or along with a gonadotropin-releasing hormone (GnRH) analog.